首頁 > 市場調查報告書 > 工業機械

機械元件流體機器閥門

市場調查報告書

商品編碼

1873998

牛心包瓣膜市場

Bovine Pericardial Valve Market

出版日期: 2025年11月01日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄

牛心包瓣膜市場預計將從2024年的31.4億美元成長到2031年的60.8億美元，2031年至2031年的年複合成長率（CAGR）為9.9%。心臟瓣膜手術報銷額的增加預計將成為牛心包瓣膜市場的重要趨勢。

牛心包瓣膜市場分析

牛心包瓣膜廣泛應用於各種醫療領域，包括生物人工心臟瓣膜、硬腦膜閉合、牙科和骨膜以及外科手術加強。心臟瓣膜手術數量的不斷增加有望促進旨在改善患者預後的創新療法的研發。

牛心包瓣膜市場概覽

由於牛心包瓣膜相比機械瓣膜具有諸多優勢，其在心血管手術（例如主動脈瓣置換術和先天性心臟病治療）的需求日益成長。這些生物瓣膜，包括牛心包瓣膜，可用於微創手術和開胸手術。這些瓣膜的一個關鍵優勢在於，它們無需終身服用華法林（機械瓣膜患者為預防血栓而必須服用），從而降低了選擇生物瓣膜患者的中風或栓塞風險。此外，生物瓣膜尤其適用於老年患者，因為老年患者在瓣膜置換手術中更容易受到華法林相關出血風險的影響。因此，預計牛心包生物瓣膜相對於機械瓣膜的優勢將在整個預測期內推動市場成長。

牛心包瓣膜市場的促進因素與機會

心臟瓣膜疾病發生率上升將推動市場成長

全球主動脈瓣置換手術數量的成長推動了對牛心包瓣膜的需求。 2024年1月發表於《跨學科心血管和胸腔外科雜誌》的一項研究分析了一項臨床試驗，該試驗納入了148例接受Cingular牛心包膜生物瓣膜主動脈瓣置換術的患者。五年的追蹤結果表明，這種創新的牛心包主動脈瓣膜具有良好的安全性和血流動力學效果。

拓展應用－兒科和先天性心臟病領域的機會

牛心包瓣膜也用於兒童心臟瓣膜置換和先天性心臟缺陷的修復。 2023年4月發表在Springer Link上的文章指出，牛心包經常被用作自體心包的替代品。牛心包膜材料（包括補片）的耐久性取決於手術技術和植入部位。使用牛心包瓣膜的手術取得的積極成果有望促使人們開發出專為兒童設計的特殊瓣膜樣式和尺寸，從而為牛心包瓣膜市場帶來未來的發展機會。

牛心包瓣膜市場細分分析

對牛心包瓣膜市場進行分析的關鍵細分市場包括瓣膜類型、合金和最終用戶。

市場按瓣膜類型分為主動脈瓣、二尖瓣和其他瓣膜，其中主動脈瓣在 2023 年佔據最大的市場佔有率。
依合金種類分類，市場分為鈷鉻合金、鈦合金、鎳鉬合金和其他合金，其中鈷鉻合金在 2023 年佔據市場佔有率領先地位。
從最終用戶來看，市場分為醫院、心臟中心和門診手術中心，其中醫院在 2023 年佔據市場主導地位。

牛心包瓣膜市場的地理分析

牛心包瓣膜市場報告的地理範圍分為五個區域：北美、亞太、歐洲、中東和非洲以及南美和中美洲。

北美一直是牛心包瓣膜市場的領先地區，這主要得益於心血管疾病和先天性心臟缺陷盛行率的上升，以及主要市場參與者的存在。生物瓣膜（例如牛心包瓣膜）作為心臟介入手術中機械瓣膜的替代方案，其應用日益廣泛，預計將進一步推動北美市場成長。此外，由於醫療旅遊業的興起和醫院數量的增加，加拿大和墨西哥也預計將迎來成長機會。預計亞太地區在未來幾年將實現最高的複合年成長率。

牛心包瓣膜市場報告範圍

牛心包瓣膜市場的最新發展

牛心包瓣膜市場評估是基於從一手和二手研究中收集的定性和定量資料，包括重要的企業出版物、協會資料和資料庫。牛心包瓣膜市場的最新發展包括：

美敦力公司推出了Avalus Ultra瓣膜，設計為方便植入和長期患者管理。這款新一代外科主動脈組織瓣膜採用聚醚醚酮（PEEK）基座框架，確保瓣膜的圓度一致性；擁有業界領先的有效瓣口面積（EOA），可增強血流；並配備不透射線的線圈，以提高未來瓣中瓣手術的可見度（來源：美敦力公司，新聞稿，2024）。
愛德華生命科學公司推出了SAPIEN 3 Ultra RESILIA瓣膜，將該公司的RESILIA組織技術與SAPIEN 3 Ultra經導管主動脈心臟瓣膜結合。 RESILIA組織是採用先進抗鈣化技術處理的牛心包組織，是包括目前正在進行臨床試驗的下一代SAPIEN X4瓣膜在內的新型瓣膜的基礎（資料來源：愛德華生命科學公司網站，2022年）。

牛心包瓣膜市場報告的覆蓋範圍和交付成果

這份題為《牛心包瓣膜市場規模及預測（2021-2031）》的報告對市場進行了全面分析，涵蓋以下領域：

涵蓋範圍內所有關鍵細分市場的全球、區域和國家層面的市場規模和預測。
市場動態，包括促進因素、限制因素和主要機會。
未來主要趨勢。
詳細的PEST/波特五力模型和SWOT分析。
全球及區域市場分析，重點在於關鍵趨勢、主要參與者、法規及最新發展。
產業格局和競爭分析，包括市場集中度、熱力圖分析、主要參與者和最新發展。
深入的公司概況。

市場促進因素
- 心血管疾病（CVD）和先天性心臟病（CHD）發生率不斷上升
- 組織瓣膜相對於機械瓣膜的優勢
市場限制
- 組織瓣膜的局限性
市場機會
- 全球醫療保健產業發展
未來趨勢
- 心臟瓣膜手術報銷額不斷成長
促進因素和約束措施的影響分析

第6章：牛心包瓣膜市場及全球分析

全球牛心包瓣膜市場收入預測與分析
全球牛心包瓣膜市場（依地理分類）－預測與分析
關鍵參與者的市場定位

第7章：牛心包瓣膜市場分析及瓣膜類型

概述
2024 年及 2031 年牛心包瓣膜市場佔有率（按瓣膜類型分類）
主動脈
二尖瓣
其他

第8章：牛心包瓣膜市場分析及合金分類

概述
2024 年及 2031 年牛心包瓣膜市場佔有率（依合金類型分類）
鈷鉻合金
鈦
鎳鉬
其他

第9章：牛心包瓣膜市場分析及最終用戶細分

概述
2024 年及 2031 年牛心包瓣膜市場佔有率（按最終用戶分類）
醫院
心臟中心
門診手術中心

第10章：牛心包瓣膜市場分析及至2031年預測及地理分析

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 南非
南美洲和中美洲
- 南美洲和中美洲
- 巴西
- 阿根廷

第11章：新冠肺炎疫情對全球牛心包瓣膜市場的影響

北美洲：新冠肺炎疫情影響評估
歐洲：新冠肺炎疫情影響評估
亞太地區：新冠肺炎疫情影響評估
世界其他地區：新冠肺炎疫情影響評估

第12章：行業概況

概述
市場中各公司採取的成長策略（%）
有機和無機發展
- 概述

第13章：公司簡介

Abbott
AFFLUENT MEDICAL SA
Boston ScientificCorporation
Braile Biomedica
Edwards LifesciencesCorporation
Labcor
LivaNova PLC
Medtronic
Meril Life SciencesPvt. Ltd.
Valcare Medical

第14章：附錄

簡介目錄

Product Code: TIPRE00008677

The bovine pericardial valve market is anticipated to grow from US$ 3.14 billion in 2024 to US$ 6.08 billion by 2031, reflecting a compound annual growth rate (CAGR) of 9.9% from 2031 to 2031. An increase in reimbursement for cardiac valve surgeries is expected to be a significant trend in the bovine pericardial valve market.

Analysis of the Bovine Pericardial Valve Market

Bovine pericardial valves are extensively utilized in various medical fields, including bio-prosthetic heart valves, dural closure, dental and bone membranes, and surgical buttressing. The rising number of heart valve interventions is likely to promote the development of innovative treatments aimed at enhancing patient outcomes.

Overview of the Bovine Pericardial Valve Market

The demand for bovine pericardial valves in cardiovascular procedures, such as aortic valve replacements and treatments for congenital heart defects, is increasing due to their benefits compared to mechanical valves. These tissue valves, including those made from bovine pericardium, can be employed in both minimally invasive and open-heart surgeries. A key advantage of these valves is that they eliminate the need for lifelong warfarin therapy, which is necessary to prevent blood clots with mechanical valves, thereby reducing the risk of stroke or embolism for patients who choose tissue valves. Additionally, bioprosthetic valves are particularly suitable for elderly patients, who are more susceptible to the bleeding risks associated with warfarin during valve replacement procedures. Consequently, the benefits of bovine pericardial bioprosthetic heart valves over mechanical options are expected to drive market growth throughout the forecast period.

Drivers and Opportunities in the Bovine Pericardial Valve Market

Increasing Incidence of Heart Valve Diseases to Boost Market

The global rise in aortic valve replacement surgeries is fueling the demand for bovine pericardial valves. A study published in the Interdisciplinary CardioVascular and Thoracic Surgery in January 2024 analyzed a clinical trial involving 148 patients who underwent surgical aortic valve replacement with Cingular bovine pericardial bioprosthesis. The five-year follow-up indicated that this innovative bovine pericardial aortic valve demonstrated favorable safety and hemodynamic results.

Expanding Uses - Opportunities in Pediatric and Congenital Heart Conditions

Bovine pericardial valves are also utilized in pediatric heart valve replacements and repairs for congenital heart defects. An article published in Springer Link in April 2023 noted that bovine pericardium is frequently used as an alternative to autologous pericardium. The durability of bovine pericardial materials, including patches, varies based on the surgical technique and implantation site. The positive outcomes from surgeries using bovine pericardial valves are expected to lead to the creation of specialized valve designs and sizes for children, presenting future opportunities for the bovine pericardial valve market.

Segmentation Analysis of the Bovine Pericardial Valve Market

Key segments contributing to the analysis of the Bovine Pericardial Valve Market include valve type, alloy, and end user.

The market is categorized by valve type into aortic, mitral, and others, with the aortic segment holding the largest market share in 2023.
By alloy, the market is divided into cobalt-chrome, titanium, nickel molybdenum, and others, with cobalt-chrome leading the market share in 2023.
In terms of end users, the market is segmented into hospitals, cardiac centers, and ambulatory surgical centers, with hospitals dominating the market in 2023.

Geographical Analysis of the Bovine Pericardial Valve Market

The geographical scope of the bovine pericardial valve market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has been the leading region in the Bovine Pericardial Valve Market, driven by the rising prevalence of cardiovascular diseases, congenital heart defects, and the presence of major market players. The increasing adoption of bioprostheses, such as bovine pericardial valves, as alternatives to mechanical valves for heart interventions is expected to further enhance market growth in North America. Additionally, growth opportunities are anticipated in Canada and Mexico due to the rise in medical tourism and an increasing number of hospitals. The Asia Pacific region is projected to experience the highest CAGR in the coming years.

Scope of the Bovine Pericardial Valve Market Report

Recent Developments in the Bovine Pericardial Valve Market

The Bovine Pericardial Valve Market is assessed through qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Recent developments in the bovine pericardial valve market include:

Medtronic introduced the Avalus Ultra valve, designed for ease of use during implantation and long-term patient management. This next-generation surgical aortic tissue valve features a polyetheretherketone (PEEK) base frame for consistent circularity, an industry-leading Effective Orifice Area (EOA) for enhanced blood flow, and a radiopaque coil for improved visibility during future valve-in-valve procedures (Source: Medtronic, Press Release, 2024).
Edwards Lifesciences Corporation launched the SAPIEN 3 Ultra RESILIA valve, which integrates the company's RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve. RESILIA tissue is treated bovine pericardial tissue with advanced anti-calcification technology, serving as the foundation for new valves, including the next-generation SAPIEN X4 valve currently in clinical trials (Source: Edwards Lifesciences, Company Website, 2022).

Coverage and Deliverables of the Bovine Pericardial Valve Market Report

The report titled "Bovine Pericardial Valve Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

Market size and forecast at global, regional, and country levels for all key segments included in the scope.
Market dynamics, including drivers, restraints, and key opportunities.
Key future trends.
Detailed PEST/Porter's Five Forces and SWOT analysis.
Global and regional market analysis, highlighting key trends, major players, regulations, and recent developments.
Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments.
In-depth company profiles.

1. Introduction

1.1 Scope of theStudy
1.2 The InsightPartners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Bovine Pericardial Valve Market and By Valve Type
- 1.3.2 Bovine Pericardial Valve Market and By Alloy
- 1.3.3 Bovine Pericardial Valve Market and By End User
- 1.3.4 Global Bovine Pericardial Valve Market and By Geography

2. Bovine Pericardial Valve Market and Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 SecondaryResearch
3.3 Primary Research

4. Bovine Pericardial Valve Market and Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America and PEST Analysis
- 4.2.2 Europe and PEST Analysis
- 4.2.3 Asia Pacific and PEST Analysis
- 4.2.4 Middle East and Africa (MEA) and PEST Analysis
- 4.2.5 South and Central America (SCAM) and PEST Analysis
4.3 Expert Opinion

5. Bovine Pericardial Valve Market and Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Incidence of Cardiovascular Diseases (CVD) and CongenitalHeart Diseases (CHD)
- 5.1.2 Advantages of Tissue Valves over Mechanical Valves
5.2 Market Restraints
- 5.2.1 Limitations Associated with Tissue Based Valves
5.3 MarketOpportunities
- 5.3.1 Developing Healthcare Industry Worldwide
5.4 Future Trends
- 5.4.1 Growing Reimbursement for Cardiac Valve Surgery
5.5 Impact Analysisof Drivers and Restraints

6. Bovine Pericardial Valve Market and Global Analysis

6.1 Global BovinePericardial Valve Market Revenue Forecast And Analysis
6.2 Global BovinePericardial Valve Market, By Geography - Forecast And Analysis
6.3 MarketPositioning of Key Players

7. Bovine Pericardial Valve Market Analysisand by Valve Type

7.1 Overview
7.2 BovinePericardial Valve Market Share, By Valve Type, 2024 and 2031 (%)
- 7.2.1 Bovine Pericardial Valve Market Revenue and Forecasts to 2031, ByValve Type (US$ MN)
7.3 Aortic
- 7.3.1 Overview
- 7.3.2 Aortic Market Revenue and Forecasts to 2031 (US$ Mn)
7.4 Mitral
- 7.4.1 Overview
- 7.4.2 Mitral Market Revenue and Forecasts to 2031 (US$ Mn)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others Market Revenue and Forecasts to 2031 (US$ Mn)

8. Bovine Pericardial Valve Market Analysisand by Alloy

8.1 Overview
8.2 BovinePericardial Valve Market Share, By Alloy, 2024 and 2031 (%)
- 8.2.1 Bovine Pericardial Valve Market Revenue and Forecasts to 2031, ByApplication (US$ Mn)
8.3 Cobalt-Chrome
- 8.3.1 Overview
- 8.3.2 Cobalt-Chrome Market Revenue and Forecasts to 2031 (US$ Mn)
8.4 Titanium
- 8.4.1 Overview
- 8.4.2 Titanium Market Revenue and Forecasts to 2031 (US$ Mn)
8.5 Nickel-Molybdenum
- 8.5.1 Overview
- 8.5.2 Nickel-Molybdenum Market Revenue and Forecasts to 2031 (US$ Mn)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others Market Revenue and Forecasts to 2031 (US$ Mn)

9. Bovine Pericardial Valve Market Analysisand by End User

9.1 Overview
9.2 BovinePericardial Valve Market Share, By End User, 2024 and 2031 (%)
- 9.2.1 Bovine Pericardial Valve Market Revenue and Forecasts to 2031, ByEnd User (US$ Mn)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals Market Revenue and Forecasts to 2031 (US$ Mn)
9.4 Cardiac Centers
- 9.4.1 Overview
- 9.4.2 Cardiac Centers Market Revenue and Forecasts to 2031 (US$ Mn)
9.5 AmbulatorySurgical Centers
- 9.5.1 Overview
- 9.5.2 Ambulatory Surgical Centers Market Revenue and Forecasts to 2031(US$ Mn)

10. Bovine Pericardial Valve Market Analysis And Forecasts To 2031 andGeographical Analysis

10.1 North America:Bovine Pericardial Valve Market
- 10.1.1 Overview
- 10.1.2 North America: Bovine Pericardial Valve Market and Revenue andForecast to 2031 (USD Million)
- 10.1.3 North America: Bovine Pericardial Valve Market, by Valve Type,2024 and 2031 (USD Million)
- 10.1.4 North America: Bovine Pericardial Valve Market, by Alloy, 2024 and 2031(USD Million)
- 10.1.5 North America: Bovine Pericardial Valve Market, by End-User, 2024 and 2031(USD Million)
- 10.1.6 North America: Bovine Pericardial Valve Market, by Country,2024 and 2031 (%)
- 10.1.7 US: Bovine Pericardial Valve Market and Revenue and Forecast to 2031(USD Million)
  - 10.1.7.1 US: Bovine Pericardial Valve Market and Revenue and Forecast to 2031(USD Million)
  - 10.1.7.2 US: Bovine Pericardial Valve Market, by Valve Type, 2024 and 2031 (USDMillion)
  - 10.1.7.3 US: Bovine Pericardial Valve Market, by Alloy, 2024 and 2031 (USDMillion)
  - 10.1.7.4 US: Bovine Pericardial Valve Market, by End-User, 2024 and 2031 (USDMillion)
- 10.1.8 Canada: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.1.8.1 Canada: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.1.8.2 Canada: Bovine Pericardial Valve Market, by Valve Type, 2024 and 2031(USD Million)
  - 10.1.8.3 Canada: Bovine Pericardial Valve Market, by Alloy, 2024 and 2031 (USDMillion)
  - 10.1.8.4 Canada: Bovine Pericardial Valve Market, by End-User, 2024 and 2031 (USDMillion)
- 10.1.9 Mexico: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.1.9.1 Mexico: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.1.9.2 Mexico: Bovine Pericardial Valve Market, by Valve Type, 2024 and 2031(USD Million)
  - 10.1.9.3 Mexico: Bovine Pericardial Valve Market, by Alloy, 2024 and 2031 (USDMillion)
  - 10.1.9.4 Mexico: Bovine Pericardial Valve Market, by End-User, 2024 and 2031 (USDMillion)
10.2 Europe: BovinePericardial Valve Market
- 10.2.1 Overview
- 10.2.2 Europe: Bovine Pericardial Valve Market - Revenue and Forecast to2031 (USD Million)
- 10.2.3 Europe Bovine Pericardial Valve Market, by Valve Type and Revenue andForecast to 2031 (USD Million)
- 10.2.4 Europe Bovine Pericardial Valve Market, by Alloy and Revenue andForecast to 2031 (USD Million)
- 10.2.5 Europe Bovine Pericardial Valve Market, by End User and Revenue andForecast to 2031 (USD Million)
- 10.2.6 Europe: Bovine Pericardial Valve Market, by Country, 2024 and 2031(%)
- 10.2.7 Germany: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.7.1 Germany: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.7.2 Germany Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.2.7.3 Germany Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.2.7.4 Germany Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.2.8 UK: Bovine Pericardial Valve Market and Revenue and Forecast to 2031(USD Million)
  - 10.2.8.1 UK: Bovine Pericardial Valve Market and Revenue and Forecast to 2031(USD Million)
  - 10.2.8.2 UK Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.2.8.3 UK Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.2.8.4 UK Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.2.9 France: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.9.1 France: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.9.2 France Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.2.9.3 France Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.2.9.4 France Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.2.10 Spain: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.10.1 Spain: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.10.2 Spain Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.2.10.3 Spain Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.2.10.4 Spain Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.2.11 Italy: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.11.1 Italy: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.2.11.2 Italy Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.2.11.3 Italy Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.2.11.4 Italy Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
10.3 Asia Pacific: BovinePericardial Valve Market
- 10.3.1 Overview
- 10.3.2 Asia Pacific: Bovine Pericardial Valve Market - Revenue and Forecastto 2031 (USD Million)
- 10.3.3 Asia Pacific Bovine Pericardial Valve Market, by Valve Type andRevenue and Forecast to 2031 (USD Million)
- 10.3.4 Asia Pacific Bovine Pericardial Valve Market, by Alloy and Revenue andForecast to 2031 (USD Million)
- 10.3.5 Asia Pacific Bovine Pericardial Valve Market, by End User and Revenueand Forecast to 2031 (USD Million)
- 10.3.6 Asia Pacific: Bovine Pericardial Valve Market, by Country, 2024 and 2031 (%)
- 10.3.7 China: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.7.1 China: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.7.2 China Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.3.7.3 China Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.3.7.4 China Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.3.8 Japan: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.8.1 Japan: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.8.2 Japan Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.3.8.3 Japan Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.3.8.4 Japan Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.3.9 India: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.9.1 India: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.9.2 India Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.3.9.3 India Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.3.9.4 India Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.3.10 South Korea: Bovine Pericardial Valve Market and Revenue and Forecastto 2031 (USD Million)
  - 10.3.10.1 South Korea: Bovine Pericardial Valve Market and Revenue and Forecastto 2031 (USD Million)
  - 10.3.10.2 South Korea Bovine Pericardial Valve Market, by ValveType and Revenue and Forecast to 2031 (USD Million)
  - 10.3.10.3 South Korea Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.3.10.4 South Korea Bovine Pericardial Valve Market, by EndUser and Revenue and Forecast to 2031 (USD Million)
- 10.3.11 Australia: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.11.1 Australia: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.3.11.2 Australia Bovine Pericardial Valve Market, by ValveType and Revenue and Forecast to 2031 (USD Million)
  - 10.3.11.3 Australia Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.3.11.4 Australia Bovine Pericardial Valve Market, by EndUser and Revenue and Forecast to 2031 (USD Million)
10.4 Middle East and Africa: Bovine Pericardial Valve Market
- 10.4.1 Overview
- 10.4.2 Middle East and Africa: Bovine Pericardial Valve Market - Revenueand Forecast to 2031 (US$ Million)
- 10.4.3 Middle East and Africa Bovine Pericardial Valve Market, by ValveType and Revenue and Forecast to 2031 (USDMillion)
- 10.4.4 Middle East and Africa Bovine Pericardial Valve Market, by Alloy andRevenue and Forecast to 2031 (USDMillion)
- 10.4.5 Middle East and Africa Bovine Pericardial Valve Market, by EndUser and Revenue and Forecast to 2031 (USDMillion)
- 10.4.6 Middle East and Africa: Bovine Pericardial Valve Market, byCountry, 2018 and 2031 (%)
- 10.4.7 Saudi Arabia: Bovine Pericardial Valve Market and Revenue and Forecastto 2031 (USD Million)
  - 10.4.7.1 Saudi Arabia: Bovine Pericardial Valve Market and Revenue and Forecastto 2031 (USD Million)
  - 10.4.7.2 Saudi Arabia Bovine Pericardial Valve Market, by ValveType and Revenue and Forecast to 2031 (USD Million)
  - 10.4.7.3 Saudi Arabia Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.4.7.4 Saudi Arabia Bovine Pericardial Valve Market, by EndUser and Revenue and Forecast to 2031 (USD Million)
- 10.4.8 UAE: Bovine Pericardial Valve Market and Revenue and Forecast to 2031(USD Million)
  - 10.4.8.1 UAE: Bovine Pericardial Valve Market and Revenue and Forecast to 2031(USD Million)
  - 10.4.8.2 UAE Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.4.8.3 UAE Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.4.8.4 UAE Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.4.9 South Africa: Bovine Pericardial Valve Market and Revenue and Forecastto 2031 (USD Million)
  - 10.4.9.1 South Africa: Bovine Pericardial Valve Market and Revenue and Forecastto 2031 (USD Million)
  - 10.4.9.2 South Africa Bovine Pericardial Valve Market, by ValveType and Revenue and Forecast to 2031 (USD Million)
  - 10.4.9.3 South Africa Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.4.9.4 South Africa Bovine Pericardial Valve Market, by EndUser and Revenue and Forecast to 2031 (USD Million)
10.5 South and CentralAmerica: Bovine Pericardial Valve Market
- 10.5.1 Overview
- 10.5.2 South and Central America: Bovine Pericardial Valve Market and Revenueand Forecast to 2031 (USD Million)
- 10.5.3 South and Central America Bovine Pericardial Valve Market, by ValveType and Revenue and Forecast to 2031 (USD Million)
- 10.5.4 South and Central America Bovine Pericardial Valve Market, by Alloyand Revenue and Forecast to 2031 (USD Million)
- 10.5.5 South and Central America Bovine Pericardial Valve Market, by EndUser and Revenue and Forecast to 2031 (USD Million)
- 10.5.6 South and Central America: Bovine Pericardial Valve Market, byCountry, 2024 and 2031 (%)
- 10.5.7 Brazil: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.5.7.1 Brazil: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.5.7.2 Brazil Bovine Pericardial Valve Market, by Valve Type and Revenue and Forecast to 2031 (USD Million)
  - 10.5.7.3 Brazil Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.5.7.4 Brazil Bovine Pericardial Valve Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 10.5.8 Argentina: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.5.8.1 Argentina: Bovine Pericardial Valve Market and Revenue and Forecast to2031 (USD Million)
  - 10.5.8.2 Argentina Bovine Pericardial Valve Market, by ValveType and Revenue and Forecast to 2031 (USD Million)
  - 10.5.8.3 Argentina Bovine Pericardial Valve Market, by Alloy and Revenue and Forecast to 2031 (USD Million)
  - 10.5.8.4 Argentina Bovine Pericardial Valve Market, by EndUser and Revenue and Forecast to 2031 (USD Million)

11. Impact of COVID-19 Pandemic on Global Bovine Pericardial ValveMarket

11.1 North America:Impact Assessment of COVID-19 Pandemic
11.2 Europe: ImpactAssessment Of COVID-19 Pandemic
11.3 Asia-Pacific: ImpactAssessment of COVID-19 Pandemic
11.4 Rest of the World: ImpactAssessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview
12.2 Growth StrategiesDone by the Companies in the Market, (%)
12.3 Organic andInorganic Developments
- 12.3.1 Overview

13. Company Profiles

13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 AFFLUENT MEDICAL SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Boston ScientificCorporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Braile Biomedica
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Edwards LifesciencesCorporation
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Labcor
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 LivaNova PLC
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Medtronic
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Meril Life SciencesPvt. Ltd.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Valcare Medical
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments